Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 311

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Vascular skin symptoms in COVID‐19: a French observational study

Open access
Bouaziz, J.D., Duong, T.A., Jachiet, M., Velter, C., Lestang, P., Cassius, C., Arsouze, A., Domergue Than Trong, E, Bagot, M., Begon, E., Sulimovic, L., Rybojad, M·2020·Journal of the European Academy of Dermatology and Venereology

Abstract

Coronavirus 19 (COVID-19) was declared as a pandemic viral infection by the World Health Organization on 11 March 2020. Usual clinical manifestations of COVID-19 infection include fever, fatigue, myalgia, headache, diarrhoea, dry cough and dyspnoea that may lead to acute respiratory distress syndrome and death.1 Skin symptoms of COVID-19 have been poorly described but may include erythematous rash, urticaria and chicken pox-like lesions.2-7 Angiotensin-converting enzyme 2 (ACE2) is a cellular receptor for COVID-19. This peculiar mode of entry of COVID-19 in human cells induces angiotensin II accumulation. Excess angiotensin II may contribute to acute lung injury and vessel dysfunction such as vasoconstriction, vascular permeability and abnormal myocardial remodelling.8 Vascular skin lesions during COVID-19 infection have never been described to date. We performed a retrospective observational nationwide study of skin lesions encountered during COVID-19 epidemic in France from 18 March 2020 to 6 April 2020 in an ambulatory setting of French dermatologists (national union of French dermatologists and venereologists, SNDV) and in 2 hospitals (Saint Louis hospital, Paris, and René Dubos hospital, Pontoise, France). All 14 patients reported had formerly proved COVID-19 infection using PCR on samples collected using nasopharyngeal swabs. Skin symptoms started a few days after first COVID-19 general symptoms unless specified in the Figure legend. All patients gave their informed consent for publication of their clinical pictures. Inflammatory lesions were reported in 7 patients: exanthema (n = 4), chicken pox-like vesicles (n = 2) and cold urticaria (n = 1) as already reported.2-7 Vascular lesions were reported in 7 patients: violaceous macules with ‘porcelain-like’ appearance (n = 1, Fig. 1A), livedo (n = 1, Fig. 1B), non-necrotic purpura (n = 1, Fig. 1 C), necrotic purpura (n = 1, Fig. 1D), chilblain appearance with Raynaud’s phenomenon (n = 1, Fig. 1E), chilblain (n = 1, Fig. 1F) and eruptive cherry angioma (n = 1, Fig. 1G). Forty other patients with chilblain lesions were reported by the SNDV, but their PCR for COVID-19 detection was either negative (n = 6) or not performed (n = 34). The pathophysiology of these lesions is unclear but may include immune dysregulation, vasculitis, vessel thrombosis or neoangiogenesis. Infected COVID-19 patients with severe respiratory distress have an increased risk of pulmonary embolism9 suggesting a hypercoagulable state of these patients. Seven patients with acro-ischaemia (toe cyanosis, skin bulla and gangrene) and frequent disseminated intravascular coagulation (4 patients) have been reported during COVID-19 epidemy in Wuhan (China).10 A well-described case of antiphospholipid syndrome has been recently published.11 Chilblain- ‘like lesions’ in our study had clinical similarities with digital changes observed in type 1 interferonopathies such as Aicardi–Goutières syndrome and STING-associated vasculopathy with onset in infancy that includes skin and pulmonary manifestations. Importantly, French dermatologists belonging to the SNDV reported numerous chilblain lesions in persons in close contact with COVID-19 + patients without COVID-19 PCR confirmation and without general symptoms of COVID-19 infections which raises 3 hypotheses: these chilblain lesions may: i/ be due to another confounding factor than COVID-19, ii/ be due to a postviral immunological reaction in asymptomatic forms of COVID-19 and iii/ represent a skin presentation of COVID-19 infection in a subgroup of patients with peculiar immune anti-viral response. As isolated sudden onset anosmia was recently described as a symptom highly suggesting COVID-19 infection,12 eruptive chilblain lesions during spring and containment may be a new symptom revealing a pauci-symptomatic COVID-19 infection. The inclusion of our patients was declarative which did not allow us to analyse the frequency of vascular skin lesions in COVID-19-affected patients. Nonetheless, clinicians should be aware of these skin symptoms to optimize COVID-19 detection and quarantine procedures. Prospective study with skin biopsies, serological and PCR analysis of COVID-19-suspected patients with vascular skin symptoms are warranted in order to understand the pathophysiology and the prognosis of such vascular skin lesions. No conflict of interest. We are fully grateful to all French dermatologists belonging to the SNDV/corona task force for their great help and for sharing their clinical experience. We also thank the SNDV non-medical staff for their great help. The patients in this manuscript have given written informed consent to the publication of their case details. None. None reported.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jdv.16544

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 311

Metadata

Authors
Bouaziz, J. D., Duong, T. A., Jachiet, M., Velter, C., Lestang, P., Cassius, C., Arsouze, A., Domergue Than Trong, E., Bagot, M., Begon, E., Sulimovic, L., & Rybojad, M.
Venue
Journal of the European Academy of Dermatology and Venereology
Publisher
Wiley
Published
2020-07-20
Volume
34
Issue
9
Pages
e451-e452
ISSN
  • 0926-9959 (ISSN-L)
  • 1468-3083
OpenAlex
W3020429260
Cited by
311
References
8
FWCI
44.87
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.